HIA
GILD icon

Highland Investment Advisors’s Gilead Sciences GILD Stock Holding History

Highland Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34K Buy
+19
New +$2.5K ﹤0.01% 487

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Highland Investment Advisors's GILD Position: Q2 2026 in Review

Highland Investment Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 19 shares worth $2.34K. The stake represents ﹤0.01% of the portfolio and ranks #487 among its holdings.

2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Highland Investment Advisors held 19 shares of Gilead Sciences worth $2.34K as of Q2 2026.
  • Gilead Sciences was a new Highland Investment Advisors position in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Highland Investment Advisors's portfolio in Q2 2026, its #487 holding.
  • 2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Highland Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.